Chromosomal Imbalance in the Progression of High-Risk Non-Muscle Invasive Bladder Cancer Editorial Comment

被引：0
|
作者：
Montie, James E.
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 03期
关键词：
D O I：
10.1016/j.juro.2009.11.100
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：938 / 939
页数：2
相关论文
共 50 条
  • [21] THE IMPACT OF REPEAT TURBT AND RESIDUAL TUMOUR ON PROGRESSION IN PRIMARY INTERMEDIATE-AND HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
    Tomaskin, R.
    Elias, B.
    Slavik, P.
    Kajo, K.
    Kliment, Jr J.
    Luptak, J.
    Grobarcikova, S.
    Kliment, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 646 - 646
  • [22] Non-muscle invasive bladder cancer risk stratification
    Isharwal, Sumit
    Konety, Badrinath
    INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 289 - 296
  • [23] Progression of high-risk non-muscle invasive bladder cancer correlates with immune phenotypes and Fibroblast Activation Protein-α (FAP)
    Muilwijk, T.
    Baekelandt, L.
    Akand, M.
    Daelemans, S.
    Marien, K.
    Waumans, Y.
    Van Dam, P-J
    Van den Broeck, T.
    Van Cleynenbreugel, B.
    Van der Aa, F.
    Gevaert, T.
    Joniau, S.
    EUROPEAN UROLOGY, 2023, 83 : S612 - S612
  • [24] Molecular predictors of non-muscle invasive bladder cancer progression
    Smal, M.
    Rolevich, A.
    Nikitchenko, N.
    Krasny, S.
    Goncharova, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 541 - 541
  • [25] Incidence, initial management and survival of high-risk non-muscle invasive bladder cancer in Northern France
    Saint, Fabien
    Pasquier, David
    Villers, Arnauld
    Massa, Jordan
    Colin, Pierre
    Vankemmel, Olivier
    Leroy, Xavier
    Bonnal, Jean-Louis
    Plouvier, Sandrine D.
    FRENCH JOURNAL OF UROLOGY, 2024, 34 (09):
  • [26] Predicting response to bacillus Calmette-Guerin in high-risk non-muscle invasive bladder cancer
    Soltani-Tehrani, Amir M.
    Kumar, Aman
    Pohar, Kamal S.
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (11) : 6489 - 6502
  • [27] Intravesical chemohyperthermia with mitomycin c for intermediate- & high-risk non-muscle invasive bladder cancer
    Lai, B. C. H.
    Wen, Y. -C.
    Shih, H. -J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 13 - 13
  • [28] Role of Tissue Markers on Predicting the Prognosis of Intermediate and High-risk Non-muscle Invasive Bladder Cancer
    Abbasli, Abulfaz
    Citgez, Sinharib
    Demirdag, Cetin
    Gurbuz, Ahmet
    Erozenci, Ahmet
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2020, 19 (04): : 177 - 181
  • [29] Biomedical markers of response to intravesical BCG treatment in high-risk non-muscle invasive bladder cancer
    Jallad, S.
    Thomas, P.
    Newport, M.
    Kern, F.
    BRITISH JOURNAL OF SURGERY, 2014, 101 : 66 - 67
  • [30] Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer
    Magalhaes, Joana C.
    Sousa, Maria
    Basto, Raquel
    Fraga, Teresa
    Gomes, Ines
    Fernandes, Catarina
    Mariano, Monica
    Paulo, Judy
    Madeira, Pedro
    Sousa, Gabriela
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
12345